TREATMENT OF PATIENTS WITH MODERATE AND SEVERE PSORIASIS - COST-OF-ILLNESS IN THE CZECH REPUBLIC

被引：2
|
作者：
Petrikova, A. [1 ]
Klimes, J. [2 ]
Dolezal, T. [3 ]
Marinov, L.
Petrova, G. [4 ]
机构：
[1] VFU Brno, Brno, Czech Republic
[2] Charles Univ Prague, Fac Pharm, CS-50165 Hradec Kralove, Czech Republic
[3] Inst Hlth Econ & Technol Assessment, Prague, Czech Republic
[4] Med Univ, Fac Pharm, Sofia, Bulgaria
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.406
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A305 / A306
页数：2
相关论文
共 50 条
  • [1] Cost of moderate to severe plaque psoriasis in Germany: A Multicenter cost-of-illness study
    Sohn, S
    Schoeffski, O
    Prinz, J
    Reich, K
    Schubert, E
    Waldorf, K
    Augustin, M
    DERMATOLOGY, 2006, 212 (02) : 137 - 144
  • [2] COST-OF-ILLNESS STUDY OF SENILE CATARACT IN THE CZECH REPUBLIC
    Kruntoradova, I
    Kruntoradova, K.
    Rogalewicz, V
    Bartak, M.
    VALUE IN HEALTH, 2014, 17 (07) : A607 - A607
  • [3] Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
    Balogh, Orsolya
    Brodszky, Valentin
    Gulacsi, Laszlo
    Heredi, Emese
    Herszenyi, Krisztina
    Jokai, Hajnalka
    Karpati, Sarolta
    Baji, Petra
    Remenyik, Eva
    Szegedi, Andrea
    Hollo, Peter
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2014, 15 : S101 - S109
  • [4] Estimation of cost-of-illness in patients with psoriasis in Switzerland
    Navarini, Alexander A.
    Laffitte, Emanuel
    Conrad, Curdin
    Piffaretti, Paolo
    Brock, Elisabeth
    Ruckdaeschel, Stephan
    Trueeb, Ralph M.
    SWISS MEDICAL WEEKLY, 2010, 140 (5-6) : 85 - 91
  • [5] COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB COMPARED TO USTEKINUMAB IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS IN THE CZECH REPUBLIC
    Klimes, J.
    Mollon, P.
    Graham, C.
    Rajnoch, J.
    Dostal, F.
    Skalicky, D.
    Jordan, P.
    Depta, J.
    VALUE IN HEALTH, 2015, 18 (07) : A424 - A424
  • [6] Treatment patterns and cost-of-illness of severe haemophilia in patients with inhibitors in Germany
    Auerswald, G
    Prondzinski, MV
    Ehlken, B
    Kreuz, W
    Kurnik, K
    Lenk, H
    Scharrer, I
    Schramm, W
    Zimmermann, R
    HAEMOPHILIA, 2004, 10 (05) : 499 - 508
  • [7] COST-OF-ILLNESS OF GENERALIZED PUSTULAR PSORIASIS IN ITALY
    Armeni, P.
    Borsoi, L.
    Costa, F.
    VALUE IN HEALTH, 2023, 26 (12) : S191 - S192
  • [8] Chronic heart failure - Impact of the condition on patients and the healthcare system in the Czech Republic: A retrospective cost-of-illness analysis
    Pavlusova, Marie
    Klimes, Jiri
    Spinar, Jindrich
    Zeman, Kamil
    Jarkovsky, Jiri
    Benesova, Klara
    Miklik, Roman
    Pohludkova, Ludmila
    Felsoci, Marian
    Vesela, Vera
    Blahovcova, Michaela
    Dostal, Filip
    Vonka, Richard
    Parenica, Jiri
    COR ET VASA, 2018, 60 (03) : E224 - E233
  • [9] COST OF MODERATE TO SEVERE PSORIASIS PATIENTS IN SPAIN
    Sanchez-Carazo, J. L.
    Dauden, E.
    Vanaclocha, F.
    Toribio, J.
    Pujol, R.
    Puig, L.
    Yebenes, M.
    Sabater, F. J.
    VALUE IN HEALTH, 2009, 12 (07) : A454 - A454
  • [10] Cost-of-illness of patients with lymphoedema
    Gutknecht, M.
    Herberger, K.
    Klose, K.
    Purwins, S.
    Dietz, D.
    Blome, C.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (11) : 1930 - 1935
12345